35
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Childhood psoriasis

, &
Pages 547-563 | Published online: 10 Jan 2014

References

  • Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J. Am. Acad. Dermatol. 60, 218–224 (2009).
  • Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr. Dermatol. 17, 174–178 (2000).
  • Silverberg NB. Pediatric psoriasis: an update. Ther. Clin. Risk Manag. 5, 849–856 (2009).
  • Vyom Sharma David Orchard. Paediatric psoriasis. Paediatr. Child Health 21(3), 126–131 (2011).
  • Sticherling M, Augusti M, Boehncke W et al. Therapy of psoriasis in childhood and adolescence – a German expert consensus. J. Dtsch. Dermatol. Ges. 9(10), 815–823 (2011).
  • Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br. J. Dermatol. 162, 633–636 (2010).
  • Swanbeck G, Inerot A, Martinsson T et al. Age at onset and different types of psoriasis. Br. J. Dermatol. 133, 768–73 (1995).
  • Farber EM, Mullen RH, Jacobs AH, Nall L. Infantile psoriasis: a follow up study. Pediatr. Dermatol. 3, 237–243 (1986).
  • Kumar B, Jain R, Sandhu K, Kaur I, Handa S. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int. J. Dermatol. 43, 654–658 (2004).
  • Li Y, Begovich AB. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin. Immunol. 21, 1–10 (2009).
  • Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128, 1207–1211 (2008).
  • Hüffmeier U, Lascorz J, Becker T et al. Characterization of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORI. J. Med. Genet. 46(11), 736–744 (2009).
  • Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology 212, 327–337 (2006).
  • Henseler T. The genetics of psoriasis. J. Am. Acad. Dermatol. 37, S1–S11 (1997).
  • Benoit S, Hamm H. Childhood psoriasis. Clin. Dermatol. 25, 555–562 (2007).
  • Takahashi H, Tsuji H, Takahashi I et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br. J. Dermatol. 159, 1207–1208, (2008).
  • Takahashi H, Tsuji H, Takahashi I et al. Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis. J. Dermatol. Sci. 54, 61–63 (2009).
  • Mobini N, Toussaint S, Kamino H, Papulosquamous disorders. In: Lever's Histopathology of Skin (10th Edition). Elder DE, Elenitsas R, Johnson BL, Murphy GF, Xu X ( Eds). Lippincott Williams & Wilkins Co, NY, USA, 69–203 (2008)
  • Leclerc-Mercier S, Bodemer C, Bourdon-Lanoy E et al. Early skin biopsy is helpful for the diagnosis and management of neonatal and infantile erythrodermas. J. Cutan. Pathol. 37, 249–255 (2010).
  • Walsh NM, Prokopetz R, Tron VA et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J. Cutan. Pathol. 21, 419 (1994).
  • Bitoun E, Micheloni A, Lamant L et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution, and defective expression in Netherton syndrome. Hum Mol. Genet. 12, 2417, (2003).
  • Pruszkowski A, Bodemer C, Fraitag S, Teillac-Hamel D, Amoric JC, de Prost Y. Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch. Dermatol. 136, 875 (2000).
  • Beer WE, Smith AE, Kassab JY, Smith PH, Rowland Payne CM. Concomitance of psoriasis and atopic dermatitis. Dermatology 184, 265–270 (1992).
  • Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis- Part II: Immune cell subsets and therapeutic concepts. J. Allergy Clin. Immunol. 127, 1420–1432 (2011).
  • Giustizieri ML, Mascia F, Frezzolini A et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J. Allergy Clin. Immunol. 107, 871–877 (2001).
  • Cookson WO, Ubhi B, Lawrence R et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27, 372–373 (2001).
  • Hoffjan S, Stemmler S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. Br. J. Dermatol. 157, 441–449 (2007).
  • Seyhan M, Cos‚kun BK, Sağlam H, Ozcan H, Karincaoğlu Y. Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr. Int. 48, 525–530 (2006).
  • Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr. Dermatol. 18, 188–198 (2001).
  • Grjibovski AM, Olsen AO, Magnus P, Harris JR. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J. Eur. Acad. Dermatol. Venereol. 21, 1337–1343 (2007).
  • Stefanaki, C, Lagogianni E, Kontochristopoulos G et al. Psoriasis in children: a retrospective analysis. J. Eur. Acad. Dermatol. Venereol. 25, 417–421 (2011).
  • Al-fouzan AS, Nanda A. A Survey of Childhood Psoriasis in Kuwait. Pediatr. Dermatol. 11, 116–119 (1994).
  • Altobelli E, Petrocelli R, Marziliano C et al. Family history of psoriasis and age at disease onset in Italian patients with psoriasis. Br. J. Dermatol. 156, 1400–1401 (2007).
  • Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J. Pediatr. 113, 1037–1039 (1988).
  • Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr. Dermatol. 20, 506–510 (2003).
  • Lazar AP, Roenigk HH. Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis. J. Am. Acad. Dermatol. 18, 144 (1988).
  • Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am. J. Clin. Dermatol. 1, 159–165 (2000).
  • Wolf R, Ruocco V. Triggered psoriasis. Adv. Exp. Med. Biol. 455, 221–225 (1999).
  • O'Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J. Drugs Dermatol. 5, 426–432 (2006).
  • S.Benoit, H.Hamm. Childhood psoriasis. Clin. Dermatol. 25, 555–562 (2007).
  • Barisic-Drusko V, Rucevic I. Trigger factors in childhood psoriasis and vitiligo. Coll. Antropol. 1, 277–285 (2004).
  • Wu Y, Lin Y, Liu HJ, Huang CZ, Feng AP, Li JW. Childhood psoriasis: A study of 137 cases from central China. World J. Pediatr. 6, 260–264 (2010).
  • Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiological survey of 112 patients. Pediatr. Dermatol. 7, 19–21 (1990).
  • Stern RS, Wu J. Psoriasis. In: Cutaneous Medicine and Surgery. Arndt KA, LeBoit PE, Robinson JK, Wintroub BU ( Eds). WB Saunders, Philadelphia (1996).
  • Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT. The natural psoriasis foundation score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physicians Global Assessment. (PGA): a comparison. J. Drugs Dermatol. 2, 260–266 (2003).
  • Dhar S, Banerjee R, Agrawal N, Chatterjee S, Malakar R. Psoriasis in children: an insight. Indian J. Dermatol. 56(3), 262–265 (2011).
  • Atherton DJ, Kahana M, Russell-Jones R. Naevoid psoriasis. Br. J. Dermatol. 120, 837–841 (1989).
  • Sarkar R, Garg VK. Erythroderma in children. Indian J. Dermatol. Venereol. Leprol. 76, 341–347 (2010).
  • Dika E, Bardazzi F, Balestri R, Maibach HI: Environmental factors and psoriasis. Curr. Probl. Dermatol. 35, 118–135 (2007).
  • Fry L, Baker BS: Triggering psoriasis: the role of infections and medications. Clin. Dermatol. 25(6), 606–615 (2007).
  • Naldi L, Gambini D: The clinical spectrum of psoriasis. Clin. Dermatol. 25(6), 510–518 (2007).
  • Sarkar R. Neonatal and infantile erythroderma: “The Red Baby”. Indian J. Dermatol. 51, 178–182 (2006)
  • Salleras M, Sanchez-Regaña M, Umbert P. Congenital erythrodermic psoriasis: case report and literature review. Pediatr. Dermatol. 12(3), 231–234 (1995).
  • Frost P, Van Scott EJ. Ichthyosiform dermatoses. Classification based on anatomic and biometric observation. Arch. Dermatol. 94, 113 (1966).
  • Parimalam K, Thomas J. Congenital Erythrodermic psoriasis – a case report. Indian J. Bio. Res. 82, 1–5 (2012).
  • Thomas J, Kumar P. Childhood psoriasis – a challenge to all. Indian. J. Pract. Ped. 13(1), 98–100 (2011).
  • Parimalam K, Thomas J, Dinesh Kumar D. Histology of infantile erythrodermic Psoriasis – a study of eight cases. J. Indian Soc. Teledermatol. 6(1), 30–35 (2012).
  • de Oliveira ST, Maragno L, Arnone M et al. Generalized pustular psoriasis in childhood. Pediatr. Dermatol. 27(4), 349–354 (2010).
  • Burden AD. Management of psoriasis in childhood. Clin. Exp. Dermatol. 24, 341–345 (1999)
  • Liao P, Rubinson R, Howard R et al. Annular pustular psoriasis – most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr. Dermatol. 19, 19–25 (2002).
  • Zelickson BD, Muller SA. Generalized pustular psoriasis in childhood. J. Am. Acad. Dermatol. 24, 186–194 (1990).
  • Xiao T, Li B, He CD et al. Juvenile generalized pustular psoriasis. J. Dermatol. 34, 573–576 (2007).
  • Judge MR, Mcdonald A, Black MM. Pustular psoriasis in childhood. Clin. Exp. Dermatol. 18, 97–99 (1993).
  • Espinoza LR, Cuellar ML, Silveira LH. Psoriatic arthritis. Curr. Opin. Rheumatol. 4, 470–478 (1992).
  • Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am. J. Clin. Dermatol. 4, 441–447 (2003).
  • Southwood TR, Petty RE, Malleson PN et al. Psoriatic arthritis in children. Arthritis Rheum. 32, 1007–1013 (1989).
  • Shore A, Ansell BM. Juvenile psoriatic arthritis – an analysis of 60 cases. J. Pediatr. 100, 529–535 (1982).
  • Mohan M P, Ramesh T C. Multiple autoimmune syndrome. Indian J. Dermatol. Venereol. Leprol. 69, 298–299 (2003).
  • Zhu KJ, He SM, Zhang C, Yang S, Zhang XJ. Relationship of the body mass index and childhood psoriasis in a Chinese Han population: a hospital-based study. J. Dermatol. Assoc. 39, 181–183 (2011).
  • Boccardi D, Menni S, La Vecchia C et al. Overweight and childhood psoriasis. Br. J. Dermatol. 161, 484–486 (2009).
  • Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 370, 263–271 (2007).
  • Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm. Venereol. 90, 147–151 (2010).
  • Fluhr JW, Cavallotti C, Berardesca E. Emollients, moisturizers and keratolytic agents in psoriasis. Clin. Dermatol. 26, 380–386 (2008).
  • Smith CH, Jackson K, Chinn S, Angus K, Barker JNWN. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex®) in the treatment of chronic, plaque type psoriasis. Clin. Exp. Dermatol. 25, 580–58 (2000).
  • Thami GP, Sarkar R. Coal tar: Past, present and future. Clin. Exp. Dermatol. 27, 99–103 (2002).
  • Borska L, Andrys C, Krejsek J et al. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckermann regimen. Pediatr. Dermatol. 26, 23–27 (2009).
  • McGill A, Frank A, Emmett N, Turnbull DM, Birch Machin MA, Reynolds NJ. The anti psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. FASEB J. 19, 1012–1014 (2005).
  • Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J. Am. Acad. Dermatol. 45, 487–498 (2001).
  • Zvulunov A, Anisfeld A, Metzker A. Efficacy of short contact therapy with dithranol in childhood psoriasis. Int. J. Dermatol. 33, 808–810 (1994).
  • Farber EM, Nall L. Childhood psoriasis. Cutis 64, 309–314 (1999).
  • Kiken DA, Silverberg NB. Atopic dermatitis in children, part 2: treatment options. Cutis 78, 401–406 (2006).
  • Kimball AB, Gold MH, Zib B, Davis MW; Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group. Clobetasol propionate emulsion formulation foam 0.05%: review of Phase II open-label and Phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J. Am. Acad. Dermatol. 59, 448–454 (2008).
  • Rim JH, Choe YB, Youn JI. Positive effect of using calcipotriol ointment with narrow band Ultraviolet B phototherapy in psoriatic patients. Photodermatol. Photoimmunol. Photomed. 18, 131–134 (2002).
  • Oranje AP, Marcoux D, Svensson A et al. Topical calcipotriol in childhood psoriasis. J. Am. Acad. Dermatol. 36, 203–208 (1997).
  • Liao YH, Chiu HC, Tseng YS, Tsai TF. Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g−1 ointment and tacrolimus 0·3 mg g−1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br. J. Dermatol. 157, 1005–1012 (2007).
  • Brune A, Miller DW, Lin P, Cotrim Russi D, Paller AS. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr. Dermatol. 24, 76–80 (2007).
  • Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol. Online J. 12(2), 7 (2006).
  • Jain VK, Aggarwal K, Jain K et al. Narrow-band UV-B phototherapy in childhood psoriasis. Int. J. Dermatol. 46, 320–322 (2007).
  • Diluvio L, Campione E, Paternò EJ, Mordenti C, El Hachem M, Chimenti S. Childhood nail psoriasis: A useful treatment with tazarotene 0.05%. Pediatr. Dermatol. 24, 332–333 (2007).
  • Holme SA, Anstey AV. Phototherapy and PUVA photochemotherapy in children. Photodermatol. Photoimmunol. Photomed. 20, 69–75 (2004).
  • Pasic A, Ceovic R, Lipozencic J et al. Phototherapy in pediatric patients. Pediatr. Dermatol. 20, 71–77 (2003).
  • Ceovic R, Pasic A, Lipozencic J et al. Treatment of childhood psoriasis. Acta Dermatovenereol. Croat. 14(4), 261–264 (2006).
  • Pang ML, Murase JE, Koo J. An updated review of acitretin a systemic retinoid for the treatment of psoriasis. Expert Opin. Drug Metab. Toxicol. 4, 953–964 (2008).
  • Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Letter. 13, 1–3 (2008).
  • Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr. Dermatol. 11(3), 271–273 (1994).
  • Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin. Exp. Dermatol. 34(3), 295–298 (2009).
  • Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J. Am. Acad. Dermatol. 60, 824–837 (2009).
  • Perrett CM, Ilchyshyn A, Berth-Jones J. Cyclosporin in childhood psoriasis. J. Dermatol. Treat. 14(2), 113–118 (2003).
  • Alli N, Gónger E, Karakayali G, Lenk N, Artóz F. The use of cyclosporin in a child with generalized pustular psoriasis. Br. J. Dermatol. 139, 754–755 (1998).
  • Pereira TM, Vieira AP, Fernandes JC, Sousa Basto AJ. Cyclosporin A treatment in severe childhood psoriasis. Eur. Acad. Dermatol. Venereol. 20, 651–656 (2006).
  • Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I. Etanercept treatment for children and adolescents with plaque psoriasis. N. Engl. J. Med. 358, 241–251 (2008).
  • Trueb RM. Therapies for childhood psoriasis. Curr. Probl. Dermatol. 38, 137–59 (2009).
  • Kress DW. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis. J. Am. Acad. Dermatol. 54, S126–S128 (2006).
  • Pereira TM, Vieira AP, Fernandes JC, Antunes H, Basto AS. Anti TNF alpha therapy in childhood pustular psoriasis. Dermatology 213, 350–352 (2006).
  • Farnsworth NN, George SJ, Hsu S. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Dermatol. Online J. 11, 11 (2005).
  • Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr. Dermatol. 21, 87–88 (2004).
  • Pahlajani N, Katz BJ, Lozano AM, Murphy F, Gottlieb A. Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children: A pilot study. Pediatr. Dermatol. 22, 161–165 (2005).
  • Pacifico L. Acute guttate psoriasis after streptococcal scarlet fever. Pediatr. Dermatol. 10, 388–389 (1993).
  • Grattan C, Burton JL, Manku M, Stewart C, Horrobin DF. Essential fatty- acid metabolites in plasma phospholipids in patients with ichthyosis vulgaris, acne vulgaris and psoriasis. Clin. Exp. Dermatol. 15, 174–176 (1990).
  • Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B et al. Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J. Immunol. 188 (10), 5160–5165 (2012).
  • Lin YK, Yen HR, Wong WR, Yang SH, Pang JH. Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment. Pediatr. Dermatol. 23, 507–510 (2006).
  • Kumar P, Nithya P, Saratha KP, Mythili PC, Manoharan K. Effect of methotrexate in juvenile generalised pustular psoriasis. J. Appl. Med. Surg. 1(3), 28–31 (2012).
  • Parimalam K, Thomas J. Infantile erythrodermic psoriasis: successful treatment with topical Calcipotriol. J. Indian Soc. Teledermatol. 5(2), 9–14 (2011).
  • Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic diseases. Br. J. Dermatol. 155, 145–151 (2006).
  • Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology 212, 123–127 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.